These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25793063)

  • 1. Risk Factors and Predictors of Mortality in Critically ill Children with Extensively-Drug Resistant Acinetobacter baumannii Infection in a Pediatric Intensive Care Unit.
    Kapoor K; Jain S; Jajoo M; Dublish S; Dabas V; Manchanda V
    Iran J Pediatr; 2014 Oct; 24(5):569-74. PubMed ID: 25793063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidrug resistant and extensively drug resistant Acinetobacter baumannii hospital infection associated with high mortality: a retrospective study in the pediatric intensive care unit.
    Shi J; Sun T; Cui Y; Wang C; Wang F; Zhou Y; Miao H; Shan Y; Zhang Y
    BMC Infect Dis; 2020 Aug; 20(1):597. PubMed ID: 32787942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical epidemiology, treatment and prognostic factors of extensively drug-resistant Acinetobacter baumannii ventilator-associated pneumonia in critically ill patients.
    Tsioutis C; Kritsotakis EI; Karageorgos SA; Stratakou S; Psarologakis C; Kokkini S; Gikas A
    Int J Antimicrob Agents; 2016 Nov; 48(5):492-497. PubMed ID: 27542315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal dissemination of extensively drug-resistant Acinetobacter baumannii producing an OXA-23 β-lactamase at a teaching hospital in Shanghai, China.
    Li Y; Guo Q; Wang P; Zhu D; Ye X; Wu S; Wang M
    J Microbiol Immunol Infect; 2015 Feb; 48(1):101-8. PubMed ID: 24863499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter case-case control study for risk factors and outcomes of extensively drug-resistant Acinetobacter baumannii bacteremia.
    Ng TM; Teng CB; Lye DC; Apisarnthanarak A
    Infect Control Hosp Epidemiol; 2014 Jan; 35(1):49-55. PubMed ID: 24334798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors of multidrug-resistant, extensively drug-resistant and pandrug-resistant Acinetobacter baumannii ventilator-associated pneumonia in a Medical Intensive Care Unit of University Hospital in Thailand.
    Inchai J; Liwsrisakun C; Theerakittikul T; Chaiwarith R; Khositsakulchai W; Pothirat C
    J Infect Chemother; 2015 Aug; 21(8):570-4. PubMed ID: 26026660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized clinical trial.
    Durante-Mangoni E; Signoriello G; Andini R; Mattei A; De Cristoforo M; Murino P; Bassetti M; Malacarne P; Petrosillo N; Galdieri N; Mocavero P; Corcione A; Viscoli C; Zarrilli R; Gallo C; Utili R
    Clin Infect Dis; 2013 Aug; 57(3):349-58. PubMed ID: 23616495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ventilator-Associated Pneumonia due to Drug-Resistant
    Čiginskienė A; Dambrauskienė A; Rello J; Adukauskienė D
    Medicina (Kaunas); 2019 Feb; 55(2):. PubMed ID: 30781896
    [No Abstract]   [Full Text] [Related]  

  • 9. Colistin-based treatment for extensively drug-resistant Acinetobacter baumannii pneumonia.
    Khawcharoenporn T; Pruetpongpun N; Tiamsak P; Rutchanawech S; Mundy LM; Apisarnthanarak A
    Int J Antimicrob Agents; 2014 Apr; 43(4):378-82. PubMed ID: 24613422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of Acinetobacter baumannii infection in critically ill surgical patients.
    Trottier V; Namias N; Pust DG; Nuwayhid Z; Manning R; Marttos AC; Dunham MB; Schulman CI; McKenney MG
    Surg Infect (Larchmt); 2007 Aug; 8(4):437-43. PubMed ID: 17883360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal spread and patient risk factors for acquisition of extensively drug-resistant Acinetobacter baumannii in a neonatal intensive care unit in Italy.
    Zarrilli R; Di Popolo A; Bagattini M; Giannouli M; Martino D; Barchitta M; Quattrocchi A; Iula VD; de Luca C; Scarcella A; Triassi M; Agodi A
    J Hosp Infect; 2012 Dec; 82(4):260-5. PubMed ID: 23102814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Factors associated with mortality in Acinetobacter baumannii infected intensive care unit patients].
    Karabay O; Yahyaoğlu M; Oğütlü A; Sandıkçı O; Tuna N; Ceylan S
    Mikrobiyol Bul; 2012 Apr; 46(2):335-7. PubMed ID: 22639324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of multidrug resistant strains of Acinetobacter baumannii isolated from pediatric intensive care unit in a Chinese tertiary hospital.
    Chen Y; Ai L; Guo P; Huang H; Wu Z; Liang X; Liao K
    BMC Infect Dis; 2018 Dec; 18(1):614. PubMed ID: 30509192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bloodstream infection caused by extensively drug-resistant Acinetobacter baumannii in cancer patients: high mortality associated with delayed treatment rather than with the degree of neutropenia.
    Freire MP; de Oliveira Garcia D; Garcia CP; Campagnari Bueno MF; Camargo CH; Kono Magri ASG; Francisco GR; Reghini R; Vieira MF; Ibrahim KY; Rossi F; Hajjar L; Levin AS; Hoff PM; Pierrotti LC; Abdala E
    Clin Microbiol Infect; 2016 Apr; 22(4):352-358. PubMed ID: 26711434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of mortality in patients with extensively drug-resistant Acinetobacter baumannii pneumonia receiving colistin therapy.
    Choi IS; Lee YJ; Wi YM; Kwan BS; Jung KH; Hong WP; Kim JM
    Int J Antimicrob Agents; 2016 Aug; 48(2):175-80. PubMed ID: 27423416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors associated with mortality of drug-resistant Acinetobacter baumannii ventilator-associated pneumonia.
    Inchai J; Pothirat C; Bumroongkit C; Limsukon A; Khositsakulchai W; Liwsrisakun C
    J Intensive Care; 2015; 3():9. PubMed ID: 27408726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquisition of imipenem-resistant Acinetobacter baumannii in a pediatric intensive care unit: A case-control study.
    Katragkou A; Kotsiou M; Antachopoulos C; Benos A; Sofianou D; Tamiolaki M; Roilides E
    Intensive Care Med; 2006 Sep; 32(9):1384-91. PubMed ID: 16788807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
    Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
    Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extensively drug-resistant Acinetobacter baumannii in a Lebanese intensive care unit: risk factors for acquisition and determination of a colonization score.
    Moghnieh R; Siblani L; Ghadban D; El Mchad H; Zeineddine R; Abdallah D; Ziade F; Sinno L; Kiwan O; Kerbaj F; El Imad Z
    J Hosp Infect; 2016 Jan; 92(1):47-53. PubMed ID: 26616413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Presentations and Outcomes of Post-Operative Central Nervous System Infection Caused by Multi-Drug-Resistant/Extensively Drug-Resistant
    Liang W; Yuan-Run Z; Min Y
    Surg Infect (Larchmt); 2019 Sep; 20(6):460-464. PubMed ID: 30942663
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.